Skilarence 30mg, magensaftresistente Tablette - 42 Swissmedic Key 66703001 Registration Holder Almirall AG Name Skilarence 30mg, magensaftresistente Tablette Date of registration 28.01.2019 Introduction of Sequence 28.01.2019 ATC-Classification Dimethyl Fumarate (L04AX07) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 10.03. Show package size 42 Index Therapeuticus (Swissmedic) 10.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price 23.67 Deductible k.A. Consumer price 43.55 Feedback FB Daily cost GTIN 7680667030010 Medication Code Synthetika Pharmacode Disponibility
Composition dimethylis fumaras 30 mg, lactosum monohydricum 36 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, polysorbatum 80, talcum, triethylis citras, simeticonum, E 171, pro compresso obducto corresp. natrium 0.45 mg. Packungsbestandteile Galenic Form Gastric juice resistant tablets Active Agent Dose Dimethylis Fumaras 30 mg
BAG: Active Agent Dose Dimethylis Fumaras 30 mg
Inactive agents Dose additional_information Acidi Methacrylici Überzug Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Ethylis Acrylatis Polymerisatum Lactose Monohydrate 36 mg Magnesii Stearas Natrii Laurilsulfas Polysorbatum 80 Pro Compresso Obducto Silica Colloidalis Anhydrica Simeticone Talcum Triethylis Citras
Source Data was imported : 07.07.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
